miR-22-3p↑ → Target TCF7L2 → Inhibit Wnt/β-catenin pathway → Inhibit proliferation and cell cycle of osteosarcoma cells and promoted apoptosis. This evidence concerns the gene TCF7L2 and osteosarcoma.